Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,867 | 895 | 86.5% |
| Travel and Lodging | $2,446 | 10 | 11.8% |
| Education | $209.40 | 8 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $2,632 | 15 | $0 (2020) |
| Amgen Inc. | $2,074 | 96 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,777 | 90 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,752 | 116 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,459 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,292 | 56 | $0 (2024) |
| PFIZER INC. | $1,207 | 67 | $0 (2024) |
| Merck Sharp & Dohme LLC | $967.23 | 44 | $0 (2022) |
| Lilly USA, LLC | $875.37 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $867.13 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,310 | 67 | ABBVIE INC. ($256.60) |
| 2023 | $2,492 | 98 | Stryker Corporation ($760.72) |
| 2022 | $1,880 | 99 | Amgen Inc. ($280.78) |
| 2021 | $1,698 | 101 | Amgen Inc. ($224.79) |
| 2020 | $3,298 | 89 | Medtronic USA, Inc. ($1,779) |
| 2019 | $3,514 | 119 | Medtronic USA, Inc. ($853.03) |
| 2018 | $2,697 | 140 | Amgen Inc. ($393.78) |
| 2017 | $3,760 | 201 | GlaxoSmithKline, LLC. ($626.52) |
All Payment Transactions
914 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Bone Health | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 11,554 | 20,468 | $1.4M | $557,410 |
| 2022 | 62 | 12,296 | 22,292 | $1.4M | $562,951 |
| 2021 | 65 | 12,410 | 22,653 | $1.4M | $579,417 |
| 2020 | 64 | 11,490 | 20,733 | $1.2M | $505,547 |
All Medicare Procedures & Services
252 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 717 | 1,634 | $431,903 | $142,886 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 582 | 582 | $155,150 | $75,943 | 48.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 30 | 3,300 | $155,284 | $60,342 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 174 | 204 | $75,576 | $25,814 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 367 | $68,631 | $23,071 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 219 | 220 | $31,661 | $15,739 | 49.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 53 | 53 | $30,460 | $14,925 | 49.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 681 | 1,081 | $28,949 | $14,170 | 48.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 610 | 852 | $28,627 | $14,024 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 694 | 1,135 | $23,971 | $11,747 | 49.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 292 | 404 | $23,917 | $11,720 | 49.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 729 | 1,374 | $23,450 | $11,502 | 49.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 595 | 595 | $22,440 | $10,982 | 48.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 46 | 51 | $21,422 | $8,406 | 39.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 554 | 874 | $16,973 | $8,320 | 49.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 118 | 203 | $16,760 | $8,211 | 49.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 667 | 1,052 | $16,348 | $8,006 | 49.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 35 | $19,949 | $7,820 | 39.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 233 | 234 | $15,070 | $7,352 | 48.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 573 | 807 | $14,558 | $7,134 | 49.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 265 | 408 | $13,823 | $6,773 | 49.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 229 | 349 | $10,526 | $5,158 | 49.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 30 | 30 | $10,277 | $5,036 | 49.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 229 | 348 | $10,231 | $5,015 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $14,572 | $3,782 | 26.0% |
About Dr. Michael Wang, MD
Dr. Michael Wang, MD is a Family Medicine healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306847447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wang, MD has received a total of $20,648 in payments from pharmaceutical and medical device companies, with $1,310 received in 2024. These payments were reported across 914 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($17,867).
As a Medicare-enrolled provider, Wang has provided services to 47,750 Medicare beneficiaries, totaling 86,146 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 252 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Naples, FL
- Active Since 08/10/2005
- Last Updated 10/24/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306847447
Products in Payments
- O-ARM-ST (Device) $1,779
- JARDIANCE (Drug) $1,027
- FARXIGA (Drug) $954.56
- MazorX - Renaissance (Device) $738.38
- ELIQUIS (Drug) $732.83
- XARELTO (Drug) $730.95
- Ozempic (Drug) $645.28
- TRULICITY (Drug) $606.90
- Otezla (Drug) $606.17
- TRADJENTA (Drug) $596.92
- TRELEGY ELLIPTA (Drug) $553.83
- EVENITY (Biological) $531.52
- N/A (Device) $454.87
- SHINGRIX (Biological) $443.69
- MYRBETRIQ (Drug) $438.60
- VRAYLAR (Drug) $402.52
- Vascepa (Drug) $399.35
- GEMTESA (Drug) $391.91
- Repatha (Biological) $343.24
- ANORO (Drug) $338.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Naples
Dr. John Diaz, Md, MD
Family Medicine — Payments: $64,662
Vladimir Mathieu, Md, MD
Family Medicine — Payments: $39,622
Ashley Langford Tunkle, M.d, M.D
Family Medicine — Payments: $20,654
Alexander Owens, Do, DO
Family Medicine — Payments: $19,554
Adam Skipper, Do, DO
Family Medicine — Payments: $14,481
Lindita Hobdari, M.d, M.D
Family Medicine — Payments: $13,711